ATAI Life Sciences BV is a pioneering biopharmaceutical company headquartered in Berlin, Germany, dedicated to transforming mental health care through the development of innovative psychedelic therapies. With a strong emphasis on addressing unmet medical needs, ATAI utilizes its proprietary technology platform to advance a diverse pipeline of treatments aimed at various mental health disorders. The company actively collaborates with prominent research institutions, positioning itself as a leader in the burgeoning psychedelics sector and emphasizing its commitment to scientific innovation and patient-centered solutions.
Click "Analyze" to generate stock analysis
ATAI Price Trend and Signals
ATAI Option Volumes & Open Interests (aggregated)
ATAI Put Call Ratios and IV (aggregated)
ATAI Financials
2025-10-23Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-17Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-17Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-17Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-17Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.